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OBJECTIVE—Heat treatment and overexpression of heat
shock protein 72 (HSP72) have been shown to protect against
high-fat diet–induced insulin resistance, but little is known about
the underlying mechanism or the target tissue of HSP action. The
purpose of this study is to determine whether in vivo heat
treatment can prevent skeletal muscle insulin resistance.
RESEARCH DESIGN AND METHODS—Male Wistar rats
were fed a high-fat diet (60% calories from fat) for 12 weeks and
received a lower-body heat treatment (41°C for 20 min) once per
week.
RESULTS—Our results show that heat treatment shifts the
metabolic characteristics of rats on a high-fat diet toward those
on a standard diet. Heat treatment improved glucose tolerance,
restored insulin-stimulated glucose transport, and increased in-
sulin signaling in soleus and extensor digitorum longus (EDL)
muscles from rats fed a high-fat diet. Heat treatment resulted in
decreased activation of Jun NH2-terminal kinase (JNK) and
inhibitor of B kinase (IKK-), stress kinases implicated in
insulin resistance, and upregulation of HSP72 and HSP25, pro-
teins previously shown to inhibit JNK and IKK- activation,
respectively. Mitochondrial citrate synthase and cytochrome
oxidase activity decreased slightly with the high-fat diet, but heat
treatment restored these activities. Data from L6 cells suggest
that one bout of heat treatment increases mitochondrial oxygen
consumption and fatty acid oxidation.
CONCLUSIONS—Our results indicate that heat treatment pro-
tects skeletal muscle from high-fat diet–induced insulin resis-
tance and provide strong evidence that HSP induction in skeletal
muscle could be a potential therapeutic treatment for obesity-
induced insulin resistance. Diabetes 58:567–578, 2009
I
nsulin resistance is associated with many related
health complications, including type 2 diabetes and
heart disease. A recent study demonstrated induc-
tion of the natural defense system of the body, heat
shock proteins (HSPs), protects against obesity-induced
insulin resistance (1). Earlier studies in patients with type
2 diabetes showed that hot tub therapy improved glycemic
control (2) and an inverse correlation between HSP72
mRNA expression and the degree of type 2 diabetes (3).
Currently, several HSP-inducing drugs are under investi-
gation or in clinical trials for diabetic neuropathy and
neurodegenerative diseases (4,5) and could be considered
for prevention of insulin resistance. However, little is
known about the mechanism behind this newly discovered
role of HSP72, whether other inducible HSPs could be
protective against insulin resistance, or the primary target
tissue of HSP action.
Skeletal muscle is the major tissue responsible for
whole-body insulin-mediated glucose uptake (6,7). HSPs
are expressed in skeletal muscle and are strongly induced
with exercise training (8,9). Overexpression of HSP72 has
been shown to reduce skeletal muscle atrophy and oxida-
tive stress with age (10). Therefore, skeletal muscle is a
logical choice as the target tissue for the beneﬁts of HSP
overexpression. Previous studies indicate basal levels of
HSPs differ between muscle ﬁber types with slow-twitch
oxidative muscles having higher constitutive expression of
HSPs than fast-twitch glycolytic muscles (11). In contrast,
fast-twitch muscles possess greater capacity for HSP
induction in response to physiological stressors and exer-
cise (11,12). It is uncertain whether HSPs would be equally
effective as mediators of insulin action in slow- and
fast-twitch muscle.
The purpose of the present study was to determine
whether weekly in vivo heat treatment could prevent
skeletal muscle insulin resistance in rats fed a high-fat diet
and elucidate mechanisms of HSP function in skeletal
muscle. We hypothesized that heat treatment allows skel-
etal muscle to adapt and resist the development of insulin
resistance as a result of increased HSP expression. Our
ﬁndings indicate that heat treatment prevents skeletal
muscle insulin resistance and stress kinase activation,
whereas increased oxygen consumption and fatty acid
oxidation in L6 cells suggest that heat treatment can
improve mitochondrial function.
RESEARCH DESIGN AND METHODS
[
14C]mannitol and 2-deoxy [1,2-
3H]glucose were purchased from American
Radiolabeled Chemicals (St. Louis, MO). Antibodies used include phospho-
Thr183/Tyr185 and total Jun NH2-terminal kinase (JNK), phospho-Ser473 and
total Akt, and inhibitor of B (IkB) (Cell Signaling, Beverly, MA); HSP72,
phospho-Ser82 and total HSP25, HSP60, and cytochrome c (Stressgen, Victo-
ria, BC, Canada); tubulin (Sigma, St. Louis, MO); cytochrome oxidase IV
subunits I and IV (Molecular Probes, Eugene, OR); citrate synthase (Alpha
Diagnostic, San Antonio, TX); uncoupling protein-3 (UCP-3; Chemicon Inter-
national, Temecula, CA); peroxisome proliferator–activated receptor
(PPAR)- coactivator 1  (PGC-1; Calbiochem, San Diego, CA); phospho–
Tyr612-IRS-1 (Biosource, Camarillo, CA); and IRS-1 (BD Biosciences, Franklin
Lakes, NJ). [
3H]palmitate was purchased from Perkin Elmer (Waltham, MA),
insulin ELISA kits from Alpco diagnostics (Salem, NH) and all other reagents
from Sigma.
Experimental animals and treatment. Male Wistar rats (100–130 g) from
Charles River Laboratories (Wilmington, MA) were housed in a temperature-
controlled (22  2°C) room with a 12:12 light/dark cycle. Animals were fed ad
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DIABETES, VOL. 58, MARCH 2009 567libitum for 12 weeks with a standard chow diet (8604; Harlan Teklad, Madison,
WI) or high-fat diet [60% calories from fat comprising lard and corn oil and 20%
calories from carbohydrates (13)]. Experiments were conducted 48 h after the
last heat or sham treatment, and rats were fasted 12 h before experimental
procedures. All protocols were approved by the Animal Care and Use
Committee of the University of Kansas Medical Center.
In vivo heat treatment. Once per week, high-fat–fed animals were anesthe-
tized with pentobarbital sodium (5 mg/100 g body wt), and the lower body was
immersed in a water bath. Body temperature was gradually increased and
maintained between 41 and 41.5°C for 20 min as monitored with a rectal
thermometer. Sham treatment maintained core temperature at 36°C. After
treatment, 5 ml 0.9% saline was administered to prevent dehydration. Prelim-
inary experiments in our laboratory established that one heat treatment per
week maintains an increase in HSP72 expression and avoids potential HSP
inhibition by repeated heat treatment (14).
Intraperitoneal glucose tolerance test. An intraperitoneal glucose toler-
ance test (IPGTT) was performed in week 11, 48 h after the last heat/sham
treatment. Overnight-fasted rats were anesthetized and given a glucose load of
2 g/kg body wt. To prevent dehydration, 5 ml 0.9% saline was administered
after the GTT.
Immunoblotting, glucose transport, and kinase assay. In week 12, rats
were anesthetized for the removal of soleus and extensor digitorum longus
(EDL) muscles. Muscles were split longitudinally to allow adequate diffusion
of substrates (11,15). Two muscle strips per rat were assessed for glucose
transport, and two strips were incubated with or without 1 mU/ml insulin for
20 min and frozen for Western blot analysis as previously described (11).
Western blots were ﬁrst probed for phosphorylated proteins and then stripped
for total protein expression. Glucose transport activity was determined using
1.5 Ci/ml 2[1,2-
3H]deoxyglucose and 0.2 Ci/ml [
14C]mannitol (11,16,17).
Activity levels of inhibitor of B kinase (IKK-) in whole-cell lysates were
assayed as previously described (18). Phosphorylated IB levels were
detected by Western blot analysis.
KNK437 incubation. Soleus muscles were isolated from 3-month-old Fischer
344 rats and subjected to 42°C heat or 35°C sham treatment for 30 min in vitro.
Subsets of muscles were incubated in 100 mol/l HSP70 inhibitor KNK437
(Calbiochem) and stimulated with 10 g/ml anisomycin (Calbiochem). HSP72
and p-JNK/JNK were detected by Western blot analysis.
Mitochondrial enzyme activity. Citrate synthase activity was assessed in
muscle lysates (prepared in the cell extraction buffer used for immunoblot-
ting; Biosource), using a modiﬁed protocol (19) by Srere (20). The absorbance
was recorded at 405 nm every 20 s for 3 min at 30°C, using a MRXII microplate
reader and kinetic software package (Dynex Technologies, Chantilly, VA). The
linear portion of the reaction curve was used to calculate activity levels of
citrate synthase, normalized to citrate synthase protein expression levels, in
micromoles per gram per minute.
For the cytochrome oxidase assay, 140 g muscle lysate in 20 mmol/l
potassium phosphate buffer (pH 7.0) and 0.2 mg dodecyl maltoside was
warmed to 30°C (21). The reaction was initiated by addition of 25 mol/l
reduced cytochrome c, and oxidation of reduced cytochrome c was followed
for 2 min at 550 nm on a DU series spectrophotometer (Beckman Coulter,
Fullerton, CA). Maximal oxidization of cytochrome c was determined by
adding potassium ferricyanide. Activity was calculated and normalized to
cytochrome c oxidase subunit 4 (Cox-4) protein expression levels (seconds
per milligram protein).
Measurement of oxygen consumption rates. L6 myoblasts from American
Type Culture Collection (Manassas, VA) were cultured in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 10% fetal bovine serum, 100 units/ml
penicillin, and 100 g/ml streptomycin. Five to six days after differentiation,
L6 cells were treated with 30 ng/ml tumor necrosis factor- (TNF-) alone or
in combination with heat treatment (43°C for 20 min), and experiments were
performed 24 h later. O2 consumption rate was determined using an Oroboros
Oxygraph-2K high resolution respirometer (Innsbruck, Austria). After baseline
stabilization, respiratory chain inhibitors were sequentially injected: 1 g/ml
oligomycin, 3 mol/l carbonyl cyanide 4-(triﬂuoromethoxy)-phenyl-hydra-
zone, 1 mol/l rotenone, and 2 mol/l myxothiazol. All values were normal-
ized to protein content, and nonmitochondrial respiration rates were
subtracted.
Fatty acid oxidation rates. Fatty acid oxidation was performed as previ-
ously described (22). Brieﬂy, L6 myotubes were heat or sham treated and
exposed to 200 mol/l palmitate coupled with 7.5% BSA (wt/vol) for 72 h. A
second heat treatment was given in the last 24 h of palmitate treatment. Cells
were washed with PBS and incubated with 200 l 125 mol/l [
3H]palmitate-
BSA solution (1 mCi/ml stock), supplemented with 1 mmol/l carnitine for 2 h
at 37°C. After incubation, solution from each well was added to 200 l cold
10% TCA and centrifuged at 3,300 rpm for 10 min. After neutralizing with 6 N
NaOH, the mixture was run though a DOWEX resin column to separate the
fatty acid oxidation intermediates and
3H-labeled water. Scintillation ﬂuid was
added to the ﬂow-through, and
3H-CPM (counts per minute) was counted.
Fatty acid oxidation rate was normalized to protein content and expressed as
nanomoles per hour per milligram.
Statistical analysis. ANOVA and two-way ANOVA were used to study
differences between groups. This was followed by a post hoc comparison
using the Student-Newman-Keuls test when necessary. Statistical signiﬁcance
was set at P  0.05.
RESULTS
Body composition, serum insulin, and glucose toler-
ance. Twelve weeks of high-fat feeding resulted in an
increase in body weight compared with chow-fed rats (Fig.
1A). Weekly heat treatment in high-fat–fed animals did not
signiﬁcantly reduce body weight, and there was no differ-
ence in food intake between the high-fat–fed groups (chow
106.05  2.72 kcal/day; high fat 114.75  1.41 kcal/day;
high fat  heat treatment 116.93  1.57 kcal/day, P  0.05
for chow vs. high fat). Epididymal fat pad weight increased
with high-fat feeding, whereas this increase was blunted in
rats subjected to heat treatment (Fig. 1B). Fasting blood
glucose levels did not change signiﬁcantly with either diet
or heat treatment (Fig. 1C). In contrast, fasting insulin
levels increased robustly in high-fat–fed rats, and heat
treatment signiﬁcantly blunted this increase (Fig. 1D).
Although high-fat–fed rats showed decreased whole-body
glucose clearance (Fig. 1E), heat treatment effectively
improved glucose clearance as further indicated by a
decrease in glucose area under the curve (Fig. 1F).
Insulin action is improved with heat treatment. We
examined the effect of heat treatment on glucose uptake,
for the ﬁrst time, in representative slow-twitch soleus (84%
type I, 7% type IIA, and 9% type IIB) and fast-twitch EDL
muscle (20% type IIA, 38% type IIB, 38% type IID, and 4%
type I) (23). In rats fed a high-fat diet, insulin-stimulated
glucose transport increased above basal (noninsulin stim-
ulated) values in both muscle types (Fig. 2A, high fat 
sham treatment). However, the insulin effect was signiﬁ-
cantly reduced compared with chow-fed insulin-sensitive
muscles. With heat treatment, insulin-stimulated glucose
transport was signiﬁcantly increased above sham-treated
soleus and EDL muscles from high-fat–fed rats.
Insulin phosphorylates and activates the insulin recep-
tor substrate (IRS1) on tyrosine residues (rev. in 24).
Phosphorylation of Tyr612 on IRS1 was reduced with the
high-fat diet (not signiﬁcantly in soleus muscle) but res-
cued fully with heat treatment in both muscles (Fig. 2B).
Downstream of IRS-1, insulin-stimulated activation of Akt
by phosphorylation on Ser473 was reduced in soleus and
EDL muscles with high-fat feeding (Fig. 2C). Akt activation
was fully rescued with heat treatment in soleus muscle
and showed a nonsigniﬁcant improvement in the EDL.
High-fat feeding reduced phosphorylation and activation
of AS160 in EDL muscles (nonsigniﬁcant decrease in
soleus muscle Fig. 2D), whereas heat treatment improved
AS160 activation in both muscles.
Induction of HP72 and inhibition of JNK with heat
treatment. HSP72 expression was unchanged in soleus
and EDL muscles with high-fat feeding. Heat treatment
resulted in a much greater increase in HSP72 expression in
EDL muscle compared with soleus (Fig. 3A). Heat treat-
ment also induced an increase in HSP72 expression in
adipose tissue and liver (adipose: chow 0.258  0.06, high
fat  sham treatment 0.287  0.09, high fat  heat
treatment 0.760  0.11, P  0.005 for high fat  heat
treatment vs. high fat  sham treatment; liver: chow
0.061  0.01, high fat  sham treatment 0.058  0.01, high
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heat treatment vs. high fat  sham treatment). JNK
activation, as measured by phosphorylation levels, in-
creased in both soleus and EDL muscles with a high-fat
diet (Fig. 3B), although to a greater extent in EDL muscles.
With heat treatment, there was a signiﬁcant reversal of
JNK activation in both muscles. As shown in Fig. 3C, the
ability of heat treatment to increase HSP72 expression in
isolated soleus muscle was blunted in the presence of the
HSP72 inhibitor, KNK437 (25). KNK treatment alone did
not inhibit HSP72 activation (data not shown). Muscle
incubation in anisomycin results in an increase in JNK
phosphorylation that can be directly inhibited by prior
heat treatment (Fig. 3D). The presence of the HSP72
inhibitor KNK437 in the incubation medium eliminated the
ability of heat treatment to decrease JNK phosphorylation.
Activation of HSP25 and inhibition of IKK with heat
treatment. Phosphorylation of HSP25 occurs in response
to heat stress. (p)-HSP25 was unaffected with diet or heat
in the soleus but was signiﬁcantly increased in EDL
muscles with heat treatment. (Fig. 4A). Phosphorylation of
HSP25 was not increased in adipose tissue (chow 0.331 
0.1, high fat  sham treatment 0.359  0.09, high fat  heat
treatment 0.563  08); however, there was a dramatic
increase in the liver (chow 0.030  0.00, high fat  sham
treatment 0.031  0.00, high fat  heat treatment 0.379 
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FIG. 1. Weekly heat treatment improves characteristics of high-fat diet–induced insulin resistance. Male Wistar rats were given a chow or high-fat
diet for 12 weeks. The high-fat–fed rats received either a lower body heat treatment (HFHT, 41°C for 20 min) or sham treatment (HFST, 36°C
for 20 min) once per week during the diet regimen. At the end of the 12-week study, body weight (A), epididymal fat pad weights (B), fasting
glucose (C), and fasting serum insulin (D) were measured. E: IPGTT. Overnight-fasted rats were injected with a glucose load of 2 g/kg body wt
i.p. Blood glucose was measured at time 0, 15, 30, 60, 90, and 120 min after injection using a glucometer. IPGTT is expressed as glucose area under
the curve in F. ***P < 0.001, **P < 0.01 HFST vs. chow; and ##P < 0.01, #P < 0.05 HFHT vs. HFST. Values are means  SE for ﬁve to seven
rats per group.
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FIG. 2. Heat treatment increases insulin-stimulated glucose uptake and phosphorylation of IRS-1, Akt, and AS160. A: Insulin-stimulated glucose
transport. Soleus and EDL from chow, high-fat diet–fed and sham-treated (HFST), and high-fat diet–fed and lower body heat–treated (HFHT)
rats were incubated in presence or absence of 1 mU/ml insulin with 2[1,2-
3H]deoxyglucose and [
14C]mannitol, and 2-deoxyglucose uptake into the
muscles was determined. Values are means  SE for 3–5 muscles for the high-fat and HFHT groups and for 11–12 muscles per group for chow.
Insulin signaling: Soleus and EDL muscles were incubated in the presence or absence of 1 mU/ml insulin for exactly 20 min. Muscle lysates were
separated with SDS-PAGE and blots were analyzed for (p)-Y612-IRS-1/IRS-1(B), (p)-S473-Akt/Akt (C), and (p)-T642-AS160/AS160 (D). , basal
(noninsulin stimulated) measurements; f, insulin-stimulated measurements. *P < 0.05 basal vs. insulin treated; ###P < 0.001, ##P < 0.01, and
#P < 0.05. Values are means  SE for ﬁve to six muscles per group.
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FIG. 3. Heat treatment induces HSP72 expression and a concomitant JNK inactivation. Soleus and EDL muscles were dissected from chow,
high-fat diet–fed and sham-treated (HFST), and high-fat diet–fed and lower body heat–treated (HFHT) rats and snap frozen in liquid nitrogen.
Lysates were subjected to Western blot analysis for HSP72/tubulin (A) and (p)-JNK/JNK (B). *P < 0.05 HFST vs. chow; ###P < 0.001 and #P <
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then exposed to sham (35°C) or heat treatment (HT, 42°C for 30 min). A reversible pharmacological inhibitor of HSP72, KNK437 (100 mol/l),
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DIABETES, VOL. 58, MARCH 2009 5710.15, P  0.05 for high fat  heat treatment vs. high fat 
sham treatment). Activity of I	K- was assessed by mea-
suring the protein levels of its downstream target IkB,
which on activation of IKK- gets phosphorylated and
targeted for degradation (26). Protein levels of IkB were
reduced with high fat in both muscles, indicating in-
creased IKK- activation (Fig. 4B). However, heat treat-
ment reversed this activation only in the EDL muscle.
Direct assessment of IKK- kinase activity showed the
same pattern of IKK- activation in soleus and EDL
muscles (Fig. 4C).
Effects of heat treatment on mitochondrial protein
expression and enzyme activity. Proteins involved in
mitochondrial metabolism, including cytochrome c, citrate
synthase, Cox-1 (encoded by the mitochondrial genome),
and Cox-4 (encoded by the nuclear genome), were as-
sessed in the current study. Our results indicate that these
mitochondrial proteins increased with the high-fat diet
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FIG. 4. Heat treatment prevents high-fat–induced IKK activation in skeletal muscles in a ﬁber type–speciﬁc pattern. Snap-frozen soleus and EDL
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572 DIABETES, VOL. 58, MARCH 2009exclusively in the EDL muscle (Fig. 5A–D). However, an
increase in mitochondrial proteins did not occur when
heat treatment was administered in parallel with the
high-fat diet. The mitochondrial HSP, HSP60, was slightly
reduced with a high-fat diet and showed a signiﬁcant
increase with heat treatment (chow 0.971  0.047, heat
treatment  sham treatment 0.834  0.033, high fat 
heat treatment 1.117  0.113; P  0.05 for high fat  sham
treatment vs. high fat  heat treatment). The HSP60
expression pattern differs from other mitochondrial pro-
teins but is consistent with the pattern of other HSPs in the
current study. Expression of UCP-3, regulated by PPAR-

(27), increased with the high-fat diet in EDL muscles, and
heat treatment further potentiated this increase (Fig. 5E).
Although high-fat feeding resulted in an increase in the
master regulator of mitochondrial biogenesis, PPAR- coac-
tivator 1  (PGC-1), this effect was not observed in high-fat
muscles given heat treatment (Fig. 5F). Mitochondrial pro-
tein expression was not signiﬁcantly altered in the soleus
muscle with diet or heat treatment (data not shown).
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sion seen with a high-fat diet, mitochondrial enzyme
activity was not maintained in EDL muscle. A 12-week
high-fat diet resulted in a slight decrease in citrate syn-
thase and cytochrome oxidase activity in EDL muscles
(Fig. 6A and B). In muscles given weekly heat treatment,
enzyme activity levels were maintained. Soleus muscle
mitochondrial enzyme activity was unchanged with diet or
heat treatment.
Acute effects of heat treatment on glucose uptake
and mitochondrial function. We measured, for the ﬁrst
time, the effects of a single heat treatment on skeletal
muscle glucose uptake and insulin signaling. As shown in
Fig. 7, 24 h after heat treatment, insulin-stimulated glucose
uptake was increased in EDL muscles above that seen
with insulin alone, with no effect of heat treatment in
soleus muscle. Basal glucose uptake was slightly in-
creased 24 h after heat treatment in both muscle types,
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ment may be optimal for glucose uptake. Phosphorylation
levels of the insulin signaling intermediates Akt and AS160
were not increased in either muscle 24 h after one heat
treatment (data not shown). Additional time points may be
necessary to determine effects of acute heat treatment on
insulin signaling.
To determine the impact acute heat treatment may have
on mitochondrial function, we measured oxygen consump-
tion in L6 muscle cells (Fig. 8A). L6 muscle cells treated with
TNF-, a cytokine known to induce mitochondrial dysfunc-
tion and insulin resistance (28), show reduced ATP-coupled
oxygen consumption compared with untreated cells (Fig.
8B). In contrast, cells given one heat treatment in the
presence of TNF- show preserved ATP-coupled oxygen
consumption. Maximal respiratory rate and proton leak
showed a nonsigniﬁcant increase with heat treatment (Fig.
8C and D). As another assessment of mitochondrial function,
fatty acid oxidation in response to palmitate and heat treat-
ment was measured in L6 cells. Exposing L6 cells to chronic
palmitate results in decreased fatty acid oxidation and insulin
resistance (29) and decreased mitochondrial enzyme activity
(30). In the current study, chronic exposure of L6 cells to
palmitate reduced the fatty acid oxidation rate, whereas heat
treatment resulted in a small but signiﬁcant increase in fatty
acid oxidation (Fig. 8E). These ﬁndings suggest that acute
heat treatment can positively enhance glucose uptake and
mitochondrial function.
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FIG. 8. Heat treatment improves oxygen consumption and fatty acid oxidation in L6 muscle cells. A: Representative tracing of O2 consumption
rates in L6 myotubes in a respirometer. Rates were determined by measuring O2 consumption in time frames O1 for baseline, O2 for rates after
1 g/ml oligomycin addition, O3 for rates after 3 mol/l FCCP addition, and O4 for rates after 1 mol/l rotenone and 2 mol/l myxothiol addition.
O2 consumption rates of L6 cells were measured under control conditions, after treatment with 20 ng/ml TNF- (24 h), and after treatment with
both 20 ng/ml TNF- (24 h) and one bout of heat treatment (43°C, 20 min, recovery 24 h). ATP-coupled oxygen consumption (B) was calculated
as the mitochondrial rate sensitive to oligomycin, proton leak (C) as the mitochondrial rate insensitive to oligomycin, and maximal uncoupled
respiration rate (D) as the O2 consumption rate after FCCP addition (50). Rates were normalized to cellular protein, calculated in pmol  s
1 
mg
1, and expressed as percentage of basal (*P < 0.001 TNF- vs. control; #P < 0.01 TNF-HT vs. TNF-). Values are means  SE for ﬁve to
six samples per group. E: L6 cells were treated with 200 mol/l palmitic acid coupled with BSA for 72 h (PA), whereas control cells received BSA
only (Basal). A subgroup of cells (PAHT) received two heat treatments (43°C, 20 min), one right before the palmitate incubation and one after
48 h. Cells were washed thoroughly, and fatty acid oxidation was assayed using 125 mol/l [
3H]palmitate-BSA. *P < 0.001 basal vs. PA and P <
0.05 basal vs. PAHT. Values are means  SE for four wells per group.
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New data in the present study demonstrate the ability of
heat treatment to restore glucose uptake and improve
insulin signaling in skeletal muscle from rats fed a high-fat
diet. Our results indicate that heat treatment can prevent
an increase in JNK phosphorylation and IKK- activation,
possibly through direct interaction with the inducible
HSPs, HSP72 and HSP25, respectively. Heat treatment
increases mitochondrial HSP60 and UCP-3 expression and
maintains mitochondrial enzyme activity in the presence
of a high-fat diet. Our ﬁndings in L6 muscle cells indicate
that acute heat treatment increases mitochondrial oxygen
consumption and fatty acid oxidation. These results pro-
vide strong evidence that HSP induction in skeletal muscle
could be a potential therapeutic treatment for obesity-
induced insulin resistance.
Twelve weeks of a high-fat diet resulted in increased
overall body weight and epididymal fat pad weight. Epi-
didymal fat pad weight was reduced with heat treatment,
although body weight and food intake remained the same
between the high-fat–fed sham and heat-treated rats.
These changes suggest an increased level of metabolism in
the animals receiving heat treatment. Whole-body hyper-
thermia has been shown to reduce plasma triglycerides
and free fatty acids in db/db mice (31), suggesting that heat
treatment improves fatty acid utilization and reduces their
accumulation. Data from the current study demonstrating
increased fatty acid oxidation in palmitate-treated muscle
cells with acute heat treatment support this idea. Future
studies are needed to measure the effects of chronic heat
treatment on fatty acid oxidation in skeletal muscle. Heat
treatment, like exercise, could increase the demand of the
cells for energy such that fatty acid uptake and utilization
are matched, reducing the accumulation of free fatty acids
and adipose tissue in the presence of a high-fat diet.
We demonstrate for the ﬁrst time that heat treatment
can restore insulin-stimulated glucose transport and in-
crease activation of insulin signaling intermediates in
skeletal muscles from high-fat–fed rats. Increased oxida-
tive stress has been strongly implicated as a cause of
diet-induced insulin resistance (32,33). Activation of
stress-induced kinases such as JNK, glycogen synthase
kinase 3, IKK-, and protein kinase C (34,35) can cause
inhibitory phosphorylation of IRS-1 on serine 307. A de-
crease in muscle oxidative stress with heat treatment
could result in decreased stress kinase activation and
improved insulin signaling. Alternatively, HSP72 and
HSP25 have been implicated as natural inhibitors of JNK
and IKK-, respectively (36,37).
In soleus and EDL muscles, an increase in HSP72
expression with heat treatment was accompanied by a
concomitant decrease in JNK activity. Our ﬁndings, com-
bined with Chung et al. (1), indicate that HSP72 protection
is strongly associated with prevention of JNK phosphory-
lation. HSP25 phosphorylation was increased in the EDL
muscles with heat treatment, and a corresponding reduc-
tion in IKK- was observed. However, without an induc-
tion of HSP25 in soleus muscle, IKK- was unchanged with
heat treatment. This suggests IKK- may not play a signif-
icant role in insulin resistance in the soleus muscle,
because insulin signaling and glucose uptake were re-
stored despite the lack of effect on IKK-. Higher consti-
tutive levels of HSPs in the soleus muscle may provide
protection from stress kinase activation, as evidenced by
much smaller activation of JNK in soleus compared with
EDL. Muscle ﬁber type differences and the potential role of
HSP25 were not explored in the previous study by Chung
et al. (1) and demonstrate the importance of ﬁber type and
pre-existing HSP levels in determining HSP function in
skeletal muscle.
Changes in mitochondrial number and function with
obesity and insulin resistance are currently controversial
in the literature (30,38–42). Our ﬁndings agree with pre-
vious studies demonstrating an increase in mitochondrial
proteins with a high-fat diet (40,41,43). Proteins involved
in mitochondrial metabolism increased with a high-fat diet
in EDL muscle; however, this increase did not occur in
high-fat–fed rats given heat treatment. It is hypothesized
that skeletal muscle mitochondrial biogenesis occurs as an
adaptation to an increased supply of fatty acids with a
high-fat diet. An increased muscle energy demand, as a
result of heat treatment given in parallel with a high-fat
diet, could reduce the accumulation of free fatty acids and
preclude the stimulus for mitochondrial biogenesis with a
high-fat diet in the EDL muscle. Interestingly, mitochon-
drial biogenesis occurs in response to a high-fat diet in
fast-twitch glycolytic and not in slow-twitch oxidative
muscle. To our knowledge, this is the ﬁrst study to make
this direct comparison in fast- and slow-twitch muscles
and could explain contradictory ﬁndings in the literature
using mixed muscle types. Oxidative muscle has greater
potential to fully oxidize lipid substrates (44) and there-
fore may not undergo adaptive mitochondrial biogenesis
in the presence of a high-fat diet.
Despite high-fat diet–induced mitochondrial biogenesis,
citrate synthase and cytochrome oxidase activities de-
creased in EDL muscle. Bonnard et al. (30) suggest a
decrease in citrate synthase activity in mice with 4 weeks
of high-fat feeding, despite any other indications of mito-
chondrial dysfunction, could reﬂect initiation of mitochon-
drial dysfunction subsequently observed with 20 weeks of
high-fat feeding. Other studies have demonstrated an
increase in mitochondrial function, as measured by oxida-
tive capacity, with a high-fat diet in parallel with increased
mitochondrial protein expression (40,41,43). It is unknown
whether muscle oxidative capacity could increase due to
enhanced fatty acid oxidation even in the presence of
decreased citrate cycle and respiratory chain enzyme
activity. Interestingly, Koves et al. (42) found that despite
high rates of fatty acid catabolism with high-fat feeding,
moderate depletion of several citrate cycle intermediates
occurred in insulin-resistant muscle. These authors hy-
pothesize that an increase in fatty acid oxidation that is
not matched by increased ﬂux through downstream mito-
chondrial pathways results in an accumulation of incom-
plete fatty acid oxidation byproducts and reactive oxygen
species (ROS) that could activate stress kinases (42,45).
In this context, heat treatment, like exercise training
(42), could result in a coordinated increase between fatty
acid oxidation and downstream mitochondrial pathways
in skeletal muscle. In support of this idea, citrate synthase
and cytochrome oxidase activity levels were restored in
EDL muscles of rats given heat treatment in the present
study. In addition, data from L6 muscle cells suggest that
heat treatment can increase fatty acid oxidation and
mitochondrial oxygen consumption. These data are sup-
ported by previous studies demonstrating that HSPs can
protect and enhance mitochondrial function (46,47). Fu-
ture studies are needed to assess chronic heat treatment
on speciﬁc steps in fatty acid metabolism in conjunction
with a high-fat diet.
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in response to heat treatment in the current study. HSP60
has been shown to protect complex IV activity in mito-
chondria (48), whereas heat treatment enhanced mito-
chondrial complex I–V activity (47). Based on previous
ﬁndings and those of the current study, the mitochondria
may be a primary target site for the protective effects of
heat treatment from oxidative stress (46). UCP-3 expres-
sion increased in response to a high-fat diet and to a
greater extent with heat treatment in the EDL muscle.
Although efforts to deﬁne UCP-3 function are ongoing, a
recent study suggests that UCP-3 induction may limit ROS
emission in conditions of lipid excess (49). Increased
UCP-3 with heat treatment could reduce ROS and enhance
metabolic ﬂux through mitochondrial pathways. Future
studies are needed to investigate these potential heat
shock–mediated mechanisms in the prevention of insulin
resistance.
In conclusion, our study shows that weekly in vivo heat
treatment can mitigate high-fat diet–induced skeletal mus-
cle insulin resistance. Our ﬁndings indicate that heat
treatment decreases JNK phosphorylation and IKK- acti-
vation, signiﬁcantly improves insulin signaling and glucose
uptake, and preserves oxidative phosphorylation capacity.
Exercise, resveratrol, the small molecule BGP-15, and
lipoic acid have all been shown to induce HSP expression.
Targeted induction of HSPs for the prevention of insulin
resistance is a realistic approach for future therapeutic
applications.
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